ISRCTN91327214已完成不适用
Simvastatin in community-acquired pneumonia requiring hospitalisation: a randomised, double-blind, placebo-controlled trial
The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)0 个研究点目标入组 376 人开始时间: 2009年2月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 376
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Immunocompetent adults (aged greater than 18 years, either sex)
- •2. Received a diagnosis of community-acquired pneumonia in the Emergency Department
- •3. Admitted to the hospital
排除标准
- •1. Absence of written informed consent
- •2. Severe immunosuppression
- •3. Pregnancy
- •4. Not able to drink and eat
- •5. Prior statin therapy
- •6. Treatment with any of the following drugs: azoles, macrolides, amiodarone, antidepressant drugs and calcium channel blockers
研究者
相似试验
进行中（未招募）
1 期
Simvastatin in patients with septic shockSeptic shockEUCTR2006-003539-56-ATMedical University of Vienna, Department of Internal Medicine IV40
已完成
4 期
A Switch Therapy for Community-acquired Pneumonia: A Randomized Controlled TrialCommunity-acquired pneumonia in adultsJPRN-UMIN000002096agasaki evaluation organization for clinical interventions100
Unknown
3 期
Effect of Simvastatin on Pneumonia Prognosis in Elderly PatientsCommunity-Acquired PneumoniaNCT01651728Indonesia University200
招募中
1 期
PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter studyCTIS2024-511053-22-00Karolinska University Hospital560
暂停
不适用
High dose simvastatin combined with standard chemotherapy in patients with refractory Multiple Myeloma: a phase II study.multiple myelomaNL-OMON20029The study is conducted on the department of hematology in het University Medical Center Utrecht. The study is approved by the Medical Ethical Board of this same hospital.12